Shashemene Comprehensive Specialized Hospital, Shashemene, Oromia Regional State, Ethiopia.
Department of Public Health, Madda Walabu University Shashemene Campus, Shashemene, Ethiopia.
BMC Womens Health. 2023 Mar 23;23(1):125. doi: 10.1186/s12905-023-02279-2.
Every year, large number of women are suffering from cervical cancer. Particularly women living with HIV are at high-risk of being suffered with it. Early testing of high-risk human papillomavirus infection can significantly reduce the incidence of cervical cancer. However, lack of early and regular testing has been identified as one of the major problems among risky populations.
Institutional-based cross-sectional study design was conducted among women living with HIV in Shashemene town public health facilities with a total sample size of 406 from February 1-March 30, 2022. Systematic random sampling technique was employed to select the study subjects. A structured questionnaire and checklist was used to collect data. The collected data were cleaned, coded, and entered into Epi-info version 7.2.5 and exported to statistical package for social science version 24 for analysis. Finally, bi-variable and multivariable logistic regression analyses were performed to identify determinants of high-risk human papillomavirus. Odds ratio with 95% confidence interval was used to test association between exposure and outcome under study and p-value < 0.05 was considered significant.
The prevalence of high-risk HPV infections among study participant was 173(35.2%) with 95% CI (30.5%-40.1%). Prevalence of high-risk HPV type 16, 18 and other high-risk HPV types were 62(15.3%), 23(5.7%) and 58(14.3%), respectively. Having history of sexually transmitted infections [AOR = 3.120; 95% CI (1.977-4.923)], Endline CD4 count < 200 cells/mm3 [AOR = 3.072; 95% CI(1.009-9.350)], Endline HIV viral-load ≥ 50 copies/ml [AOR = 3.446; 95% CI(1.368-8.683)] and more than one-lifetime sexual partner [AOR = 2.112; 95% CI(1.297-3.441)] were significantly associated with high-risk HPV infections.
More than one third of women living with HIV had high-risk HPV. Having history of STI, low CD4 count, high viral load and multiple sexual partners were associated with high risk HPV. HIV positive women with these risk factors should be given special consideration in clinical and public health intervention.
每年都有大量女性罹患宫颈癌,而感染 HIV 的女性尤其容易受到影响。对高危型人乳头瘤病毒(HPV)感染的早期检测可以显著降低宫颈癌的发病率。然而,高危人群中普遍存在的一个主要问题是缺乏早期和定期的检测。
2022 年 2 月 1 日至 3 月 30 日,在沙舍梅恩镇公共卫生机构中,对感染 HIV 的女性进行了基于机构的横断面研究,共有 406 名女性纳入研究。采用系统随机抽样技术选择研究对象。使用结构化问卷和检查表收集数据。收集的数据经过清理、编码并输入 Epi-info 版本 7.2.5,并导出到统计软件包社会科学版本 24 进行分析。最后,进行了单变量和多变量逻辑回归分析,以确定高危型 HPV 的决定因素。比值比(OR)及其 95%置信区间(CI)用于检验研究中暴露与结局之间的关联,p 值<0.05 被认为具有统计学意义。
研究参与者中高危 HPV 感染的患病率为 173 例(35.2%),95%CI(30.5%-40.1%)。高危 HPV 型 16、18 和其他高危 HPV 型的患病率分别为 62 例(15.3%)、23 例(5.7%)和 58 例(14.3%)。性传播感染史(AOR=3.120;95%CI(1.977-4.923))、终点 CD4 计数<200 个细胞/mm3(AOR=3.072;95%CI(1.009-9.350))、终点 HIV 病毒载量≥50 拷贝/ml(AOR=3.446;95%CI(1.368-8.683))和多于一个性伴侣(AOR=2.112;95%CI(1.297-3.441))与高危 HPV 感染显著相关。
超过三分之一的感染 HIV 的女性存在高危 HPV。性传播感染史、低 CD4 计数、高病毒载量和多个性伴侣与高危 HPV 相关。具有这些危险因素的 HIV 阳性女性应在临床和公共卫生干预中得到特别关注。